Sagimet Biosciences Inc.
SGMT
$2.21
$0.199.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.20M | -14.62M | -8.12M | -6.63M | -8.15M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.52M | 1.06M | 1.01M | 602.00K | 1.35M |
| Change in Net Operating Assets | 3.66M | -6.01M | 1.48M | -181.00K | -280.00K |
| Cash from Operations | -11.02M | -19.57M | -5.63M | -6.21M | -7.08M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.85M | 624.00K | -75.16M | 3.00M | -19.62M |
| Cash from Investing | 9.85M | 624.00K | -75.16M | 3.00M | -19.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 105.86M | 3.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -27.00K | -1.02M | -3.52M |
| Cash from Financing | 0.00 | 0.00 | -27.00K | 104.85M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.17M | -18.95M | -80.82M | 101.64M | -26.70M |